Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home - a Multi-center Randomized Controlled Trial

NCT05204888 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT05204888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05204888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home - a Multi-center Randomized Controlled Trial
Lead sponsor
Temple University
Phase
Not applicable
Overall status
Recruiting
Start date
February 2, 2022
Completion date
March 31, 2027
Enrollment
642 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

copd